Scott J. Dooley, PhD

Scott is focused on planning new programs and deriving value from our company’s ongoing work through IP generation and capture. He is a genetic engineer with more than a decade of experience in genetics and gene therapy. Throughout his career Scott has integrated computer and biological sciences to design and implement creative gene therapy strategies. Prior to joining Interius, he worked at Spirovant Sciences, as well as Limelight Bio, where he developed lentivirus and AAV platforms for the treatment of diseases with unmet needs.

Scott received his BA degree in genetics from Rutgers University and his PhD in cellular and molecular biology with a concentration in gene therapy from the University of Pennsylvania.